Diabetes complications

Cardiovascular autonomic neuropathy defined by indices of heart rate variability is associated with cardiovascular disease: a longitudinal cohort study of participants with type 1 diabetes

Cardiovasc DiabetolPublished Longitudinal cohort study

Main finding · First occurrence of any-CVDResult — go to the resultHazard ratio 2.37 95% CI 1.43,3.94

Authors' conclusion

The prevalence of and risk factors for standard resting ECG-derived CAN were similar to previously reported estimates from CARTs. CVD risk was significantly higher in those with vs. without CAN. These data support future studies examining the diagnostic utility of HRV indices at the point of care for risk stratification.

Study context

Population
Adults with T1D from the Epidemiology of Diabetes Interventions and Complications (EDIC) study, 2015–2022; mean ± SD age 56.2 ± 6.8 years, T1D duration 34.7 ± 7.9 years, 48% female
Participants
997 adults
Exposure
Electrocardiogram (ECG)-derived cardiovascular autonomic neuropathy (CAN) vs no CAN
Outcome
First occurrence of any-CVD
Follow-up
7 years
Methodological detailsannual standard resting ECG recordings, CAN defined by heart rate variability (HRV) indices (SDNN, rMSSD) with cut-offs validated against cardiovascular reflex tests (CARTs)
  • Annual standard resting ECG recordings
  • CAN defined by HRV indices (SDNN, rMSSD) with cut-offs validated against CARTs

Main finding

As reported in the abstract

Hazard ratio

2.37

95% CI 1.43,3.94

CANvs No CAN
HR 2.37 (95% CI 1.43,3.94)

Observational data: associations, not effects.

Further findings

Prevalence of ECG-derived CAN

Prevalence of ECG-derived CAN, stable
≈64%

Risk factors for CAN

Higher pulse rate, OR [95% CI] per 1 bpm
1.08 [1.07,1.10]
HbA1c, OR [95% CI] per 1%
1.43 [1.29,1.58]
Followed by older age, male sex, higher albumin excretion rate and hypertension history

Original publication

Cardiovascular autonomic neuropathy defined by indices of heart rate variability is associated with cardiovascular disease: a longitudinal cohort study of participants with type 1 diabetes. Cardiovasc Diabetol. Published 13 August 2025. doi:10.1186/s12933-025-02856-9

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.